Related Funds
Fund Name | Location |
Altera Capital Group | Luxembourg, Luxembourg |
Benefit Street Partners | New York, New York, United States |
Canada media fund | Canada, Ontario, Toronto |
DIA Management | England, London, United Kingdom |
Engineering and Physical Sciences Research Council | Swindon, United Kingdom, Wiltshire |
Hudson Capital Group | Florida, Fort Lauderdale, United States |
iMinds Ventures | California, San Francisco, United States |
Interfase Capital Partners | Austin, Texas, United States |
Intuitive Investments Group | England, London, United Kingdom |
Janus Henderson Investors | England, London, United Kingdom |
Jones Lang LaSalle Japan | Japan, Tokyo |
Kasasa | Austin, Texas, United States |
Kuanhua Investment Group | China, Hangzhou, Zhejiang |
LongTec China Ventures | China, Shanghai |
Merrill Lynch Ventures | New York, New York, United States |
Moelis & Company | New York, New York, United States |
Moji Fengyun (Beijing) Software Technology Development Co. | Beijing, Beijing, China |
Southern California Public Radio | California, Pasadena, United States |
The Opportunity Calgary Investment Fund | Alberta, Calgary, Canada |
Wuhan Mutual Entertainment Cultural Industry Investment Management | China, Hubei, Wuhan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Horizon Surgical Systems | 16 Oct 2024 | Malibu, California, United States | |||
Digestiva | $18M | 15 Jul 2024 | Sacramento, California, United States | ||
TORL BioTherapeutics | $158M | 10 Apr 2024 | Los Angeles, California, United States | ||
TORL BioTherapeutics | $158M | 13 Apr 2023 | Los Angeles, California, United States | ||
Eikon Therapeutics | $518M | 06 Jan 2022 | Hayward, California, United States | ||
A2 Biotherapeutics | $71M | 06 Oct 2020 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Horizon Surgical Systems | 16 Oct 2024 | Malibu, California, United States | |||
Digestiva | $18M | 15 Jul 2024 | Sacramento, California, United States | ||
TORL BioTherapeutics | $158M | 10 Apr 2024 | Los Angeles, California, United States | ||
TORL BioTherapeutics | $158M | 13 Apr 2023 | Los Angeles, California, United States | ||
Eikon Therapeutics | $518M | 06 Jan 2022 | Hayward, California, United States | ||
A2 Biotherapeutics | $71M | 06 Oct 2020 | California, United States |